candesartan has been researched along with Acute Confusional Senile Dementia in 4 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan was associated with improved whole brain CVR compared to placebo in the CEDAR study (adjusted within-group mean difference for candesartan = 0." | 3.01 | Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials. ( Hajjar, I; Henley, B; Kulshreshtha, A; Okafor, M; Trammell, A, 2023) |
| "Alzheimer's disease is the most frequent age-related dementia, and is currently without treatment." | 1.43 | An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease. ( Elkahloun, AG; Hafko, R; Saavedra, JM, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henley, B | 1 |
| Okafor, M | 1 |
| Kulshreshtha, A | 1 |
| Trammell, A | 1 |
| Hajjar, I | 1 |
| Torika, N | 1 |
| Asraf, K | 1 |
| Apte, RN | 1 |
| Fleisher-Berkovich, S | 1 |
| Trigiani, LJ | 1 |
| Royea, J | 1 |
| Lacalle-Aurioles, M | 1 |
| Tong, XK | 1 |
| Hamel, E | 1 |
| Elkahloun, AG | 1 |
| Hafko, R | 1 |
| Saavedra, JM | 1 |
1 review available for candesartan and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials.
Topics: Aged; Alzheimer Disease; Carbon Dioxide; Cognitive Dysfunction; Female; Humans; Lisinopril; Male; Ra | 2023 |
3 other studies available for candesartan and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Candesartan ameliorates brain inflammation associated with Alzheimer's disease.
Topics: Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents, Non-S | 2018 |
Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Angiotensin II Type 1 Receptor Blockers; Animals; | 2018 |
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Apopto | 2016 |